Genome-wide oligonucleotide array comparative genomic hybridization for etiological diagnosis of mental retardation: a multicenter experience of 1499 clinical cases
- PMID: 20093387
- PMCID: PMC2871727
- DOI: 10.2353/jmoldx.2010.090115
Genome-wide oligonucleotide array comparative genomic hybridization for etiological diagnosis of mental retardation: a multicenter experience of 1499 clinical cases
Abstract
To assess the clinical utility of genome-wide oligonucleotide arrays in diagnosis of mental retardation and to address issues relating to interpretation of copy number changes (CNCs), we collected results on a total of 1499 proband patients from five academic diagnostic laboratories where the same 44K array platform has been used. Three of the five laboratories achieved a diagnostic yield of 14% and the other two had a yield of 11 and 7%, respectively. Approximately 80% of the abnormal cases had a single segment deletion or duplication, whereas the remaining 20% had a compound genomic imbalance involving two or more DNA segments. Deletion of 16p11.2 is a common microdeletion syndrome associated with mental retardation. We classified pathogenic CNCs into six groups according to the structural changes. Our data have demonstrated that the 44K platform provides a reasonable resolution for clinical use and a size of 300 kb can be used as a practical cutoff for further investigations of the clinical relevance of a CNC detected with this platform. We have discussed in depth the issues associated with the clinical use of array CGH and provided guidance for interpretation, reporting, and counseling of test results based on our experience.
Figures

Similar articles
-
[Genomic abnormalities in children with mental retardation and autism: the use of comparative genomic hybridization in situ (HRCGH) and molecular karyotyping with DNA-microchips (array CGH)].Zh Nevrol Psikhiatr Im S S Korsakova. 2013;113(8):46-9. Zh Nevrol Psikhiatr Im S S Korsakova. 2013. PMID: 24077551 Russian.
-
Novel applications of array comparative genomic hybridization in molecular diagnostics.Expert Rev Mol Diagn. 2018 Jun;18(6):531-542. doi: 10.1080/14737159.2018.1479253. Epub 2018 May 31. Expert Rev Mol Diagn. 2018. PMID: 29848116 Review.
-
An oligonucleotide based array-CGH system for detection of genome wide copy number changes including subtelomeric regions for genetic evaluation of mental retardation.Am J Med Genet A. 2007 Apr 15;143A(8):824-9. doi: 10.1002/ajmg.a.31656. Am J Med Genet A. 2007. PMID: 17366576
-
A three-step workflow procedure for the interpretation of array-based comparative genome hybridization results in patients with idiopathic mental retardation and congenital anomalies.Genet Med. 2010 Aug;12(8):478-85. doi: 10.1097/GIM.0b013e3181e3914a. Genet Med. 2010. PMID: 20734469 Review.
-
Array CGH analysis of a cohort of Russian patients with intellectual disability.Gene. 2014 Feb 15;536(1):145-50. doi: 10.1016/j.gene.2013.11.029. Epub 2013 Nov 27. Gene. 2014. PMID: 24291026
Cited by
-
Chromosomal Microarray Analysis in Turkish Patients with Unexplained Developmental Delay and Intellectual Developmental Disorders.Noro Psikiyatr Ars. 2020 May 5;57(3):177-191. doi: 10.29399/npa.24890. eCollection 2020 Sep. Noro Psikiyatr Ars. 2020. PMID: 32952419 Free PMC article.
-
Craniofacial and Neurological Phenotype in a Patient with De Novo 18q Microdeletion and 18p Microduplication.Adv Exp Med Biol. 2020;1195:163-166. doi: 10.1007/978-3-030-32633-3_22. Adv Exp Med Biol. 2020. PMID: 32468472
-
Application of array-comparative genomic hybridization in tetralogy of Fallot.Medicine (Baltimore). 2016 Dec;95(49):e5552. doi: 10.1097/MD.0000000000005552. Medicine (Baltimore). 2016. PMID: 27930557 Free PMC article.
-
Exon-focused targeted oligonucleotide microarray design increases detection of clinically relevant variants across multiple NHS genomic centres.NPJ Genom Med. 2020 Jul 21;5:28. doi: 10.1038/s41525-020-0136-1. eCollection 2020. NPJ Genom Med. 2020. PMID: 32714564 Free PMC article.
-
Genotype-Phenotype Correlations for Putative Haploinsufficient Genes in Deletions of 6q26-q27: Report of Eight Patients and Review of Literature.Glob Med Genet. 2022 Mar 11;9(2):166-174. doi: 10.1055/s-0042-1743568. eCollection 2022 Jun. Glob Med Genet. 2022. PMID: 35707784 Free PMC article.
References
-
- Roeleveld N, Zielhuis GA, Gabreels F. The prevalence of mental retardation: a critical review of recent literature. Dev Med Child Neurol. 1997;39:125–132. - PubMed
-
- Pope A, Tarlov A. Disability in America: Toward a National Agenda for Prevention. Institute of Medicine; Washington, DC: 1991.
-
- Shevell MI, Majnemer A, Morin I. Etiologic yield of cerebral palsy: a contemporary case series. Pediatr Neurol. 2003;28:352–359. - PubMed
-
- Shaffer LG, Theisen A, Bejjani BA, Ballif BC, Aylsworth AS, Lim C, McDonald M, Ellison JW, Kostiner D, Saitta S, Shaikh T. The discovery of microdeletion syndromes in the post-genomic era: review of the methodology and characterization of a new 1q41q42 microdeletion syndrome. Genet Med. 2007;9:607–616. - PubMed
-
- Koolen DA, Pfundt R, de Leeuw N, Hehir-Kwa JY, Nillesen WM, Neefs I, Scheltinga I, Sistermans E, Smeets D, Brunner HG, van Kessel AG, Veltman JA, de Vries BB. Genomic microarrays in mental retardation: a practical workflow for diagnostic applications. Hum Mutat. 2009;30:283–292. - PubMed
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources